Dosing errors with compounded weight-loss products resulted in patients taking significantly higher doses than intended, leading to severe symptoms such as vomiting and pancreatitis.
Confusion between milliliters and milligrams contributed to dosing mistakes, with one patient receiving five times the intended dose and experiencing severe vomiting.
Compounded semaglutide products come in different containers from FDA-approved versions, posing higher risks; these should only be used when necessary medical needs can't be met by approved drugs.
Collection
[
|
...
]